During this segment, Arthur Garson, Jr, MD, MPH, highlights the benefits of an evolving hospital discharge program, Grand-Aides.
Dr Garson discusses the role of a Grand-Aide, commonly a certified nurse aide, and his or her responsibilities to the patient and family members following discharge. He further explains that the Grand-Aide is not the decision maker for the patient, but rather a director of the patient’s care. Through telemedicine, the Grand-Aide records video and relays important information back and forth between a medical supervisor and the patient and family.
Dr Garson also discusses how the Grand-Aides program developed, and explains how the program has effectively improved patient care and reduced hospitalization costs, overall lengths of stay, and rates of readmission.
As this new model of care continues to evolve, Dr Garson explains, it will be important for the CMS to support payment for telemedicine and the Grand-Aides program.
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Lp(a) and Getting a Head Start Against Heart Disease: Jeremy Wigginton, MD
April 8th 2025Lipoprotein a (Lp[a]) is a valuable tool for assessing a patient's risk of cardiovascular disease, which can facilitate earlier intervention efforts and reduce health care costs, argued Jeremy Wigginton, MD.
Read More